Sales rise 20.08% to Rs 5113.60 crore
Net profit of Zydus Lifesciences rose 13.80% to Rs 911.20 crore in the quarter ended September 2024 as against Rs 800.70 crore during the previous quarter ended September 2023. Sales rose 20.08% to Rs 5113.60 crore in the quarter ended September 2024 as against Rs 4258.60 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales5113.604258.60 20 OPM %28.5826.91 -PBDT1504.501191.40 26 PBT1270.901007.20 26 NP911.20800.70 14Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Modi, Narendra Modi")
 "Stock Market, BSE, NSE, Nifty, Capital, Market")
 "Anurag Thakur,Anurag")
 "Mohd Shami")
 "Market, BSE, NSE, NIfty, Stock Market, investment")
